What Is Quality by Design and Why It Matters in PharmaUntitledA Practical, Regulator-Ready Skill Set
Quality by Design Training in Kazakhstan equips pharmaceutical and biopharmaceutical professionals to build quality into products from the development stage rather than inspecting it in at the end. Quality by Design (QbD) is a systematic, science-based approach mandated by the ICH Q8, Q9, Q10 and Q11 guidelines and increasingly expected by regulators such as the FDA and EMA. Over one intensive day you learn to apply the core QbD toolkit: the Quality Target Product Profile (QTPP), Critical Quality Attributes (CQAs), risk assessment, Design of Experiments (DoE), the design space and the control strategy. Hands-on exercises use realistic scenarios drawn from both small molecule and biologic products. As Kazakhstan raises domestic medicine production and new GMP-compliant plants come online in Almaty, Shymkent and Karaganda, employers increasingly value staff who can develop products the modern, regulator-ready way. The training gives formulation, process, analytical, quality and regulatory professionals a practical skill set they can use straight away.










